Last reviewed · How we verify
MT2004
At a glance
| Generic name | MT2004 |
|---|---|
| Also known as | MT2004 |
| Sponsor | Xi'an Biocare Pharma Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects (PHASE2)
- A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MT2004 CI brief — competitive landscape report
- MT2004 updates RSS · CI watch RSS
- Xi'an Biocare Pharma Ltd. portfolio CI